Cargando…

Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats

Background: Intestinal mucosal barrier dysfunction plays an important role in the development of diabetes mellitus (DM). Berberine (BBR), a kind of isoquinoline alkaloid, is widely known to be effective for both DM and diarrhea. Here, we explored whether the anti-diabetic effect of BBR was related t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Jing, Hu, Meilin, Huang, Zhaoyi, Fang, Ke, Wang, Dingkun, Chen, Qingjie, Li, Jingbin, Yang, Desen, Zou, Xin, Xu, Lijun, Wang, Kaifu, Dong, Hui, Lu, Fuer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290458/ https://www.ncbi.nlm.nih.gov/pubmed/28217099 http://dx.doi.org/10.3389/fphar.2017.00042

Ejemplares similares

Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats
por: Chen, Qingjie, et al.
Publicado: (2017)

Berberine Alleviates Insulin Resistance and Inflammation via Inhibiting the LTB4–BLT1 Axis
por: Gong, Minmin, et al.
Publicado: (2021)

Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction
por: Qin, Xin, et al.
Publicado: (2019)

Inhibitory effects of berberine on proinflammatory M1 macrophage polarization through interfering with the interaction between TLR4 and MyD88
por: Gong, Jing, et al.
Publicado: (2019)

Berberine Ameliorates Spatial Learning Memory Impairment and Modulates Cholinergic Anti-Inflammatory Pathway in Diabetic Rats
por: Wang, Kaifu, et al.
Publicado: (2019)

Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus
por: He, Qiongyao, et al.
Publicado: (2022)

Treatment of Spleen-Deficiency Syndrome With Atractyloside A From Bran-Processed Atractylodes lancea by Protection of the Intestinal Mucosal Barrier
por: Tu, Jiyuan, et al.
Publicado: (2020)

Jiao Tai Wan Attenuates Hepatic Lipid Accumulation in Type 2 Diabetes Mellitus
por: Huang, Zhaoyi, et al.
Publicado: (2013)

Intestinal Mucosal Barrier Is Regulated by Intestinal Tract Neuro-Immune Interplay
por: You, Xin-yu, et al.
Publicado: (2021)

Berberine enhances the function of db/db mice islet β cell through GLP-1/GLP-1R/PKA signaling pathway in intestinal L cell and islet α cell
por: Wu, Wenbin, et al.
Publicado: (2023)

Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase
por: Yue, Bei, et al.
Publicado: (2021)

Effects of Intestinal FXR-Related Molecules on Intestinal Mucosal Barriers in Biliary Tract Obstruction
por: Yan, Meng, et al.
Publicado: (2022)

The Role of Berberine in the Prevention of HIF-1α Activation to Alleviate Adipose Tissue Fibrosis in High-Fat-Diet-Induced Obese Mice
por: Hu, Meilin, et al.
Publicado: (2018)

Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma
por: Hu, Qian, et al.
Publicado: (2018)

Berberine Attenuates Chronic Atrophic Gastritis Induced by MNNG and Its Potential Mechanism
por: Tong, Yuling, et al.
Publicado: (2021)

Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway
por: Dong, Yalan, et al.
Publicado: (2022)

Mechanism of Qingchang Suppository on repairing the intestinal mucosal barrier in ulcerative colitis
por: Shan, Jingyi, et al.
Publicado: (2023)

Volatile Oil from Amomi Fructus Attenuates 5-Fluorouracil-Induced Intestinal Mucositis
por: Zhang, Ting, et al.
Publicado: (2017)

Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
por: Liu, Xianzhi, et al.
Publicado: (2022)

Repairing the intestinal mucosal barrier of traditional Chinese medicine for ulcerative colitis: a review
por: Zong, Yichen, et al.
Publicado: (2023)

Qingchang Wenzhong Decoction Accelerates Intestinal Mucosal Healing Through Modulation of Dysregulated Gut Microbiome, Intestinal Barrier and Immune Responses in Mice
por: Sun, Zhongmei, et al.
Publicado: (2021)

The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Hu, Qian, et al.
Publicado: (2020)

Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Ye, Yu, et al.
Publicado: (2021)

Berberine Reduces Aβ(42) Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress
por: Wu, Yue, et al.
Publicado: (2021)

Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis
por: Du, Yishan, et al.
Publicado: (2022)

Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats
por: Li, Donghao, et al.
Publicado: (2017)

The effects of Jiao-Tai-Wan on sleep, inflammation and insulin resistance in obesity-resistant rats with chronic partial sleep deprivation
por: Zou, Xin, et al.
Publicado: (2017)

Rhubarb polysaccharide and berberine co-assembled nanoparticles ameliorate ulcerative colitis by regulating the intestinal flora
por: Feng, Yifan, et al.
Publicado: (2023)

Hu-Lu-Ba-Wan Attenuates Diabetic Nephropathy in Type 2 Diabetic Rats through PKC-α/NADPH Oxidase Signaling Pathway
por: Zhou, Lishan, et al.
Publicado: (2013)

Interleukin-4 Receptor α Subunit Deficiency Alleviates Murine Intestinal Inflammation In Vivo Through the Enhancement of Intestinal Mucosal Barrier Function
por: Hertati, Ai, et al.
Publicado: (2020)

Therapeutic effects and mechanisms of plant-derived natural compounds against intestinal mucositis
por: Li, Cailan, et al.
Publicado: (2022)

Berberine Attenuates Macrophages Infiltration in Intracranial Aneurysms Potentially Through FAK/Grp78/UPR Axis
por: Quan, Kai, et al.
Publicado: (2018)

Berberine Prevents Intestinal Mucosal Barrier Damage During Early Phase of Sepsis in Rat through the Toll-Like Receptors Signaling Pathway
por: Li, Guo-xun, et al.
Publicado: (2015)

Herb Formula (GCis) Prevents Pulmonary Infection Secondary to Intracerebral Hemorrhage by Enhancing Peripheral Immunity and Intestinal Mucosal Immune Barrier
por: Miao, Yulu, et al.
Publicado: (2022)

Diosgenin and 5-Methoxypsoralen Ameliorate Insulin Resistance through ER-α/PI3K/Akt-Signaling Pathways in HepG2 Cells
por: Fang, Ke, et al.
Publicado: (2016)

Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021)

Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients
por: Pan, Zhaoyi, et al.
Publicado: (2023)

Emodin Protects Sepsis Associated Damage to the Intestinal Mucosal Barrier Through the VDR/ Nrf2 /HO-1 Pathway
por: Shang, Luorui, et al.
Publicado: (2021)

Berberine Ameliorates High Glucose-Induced Cardiomyocyte Injury via AMPK Signaling Activation to Stimulate Mitochondrial Biogenesis and Restore Autophagic Flux
por: Hang, Weijian, et al.
Publicado: (2018)

Berberine Attenuates Cerebral Ischemia-Reperfusion Injury Induced Neuronal Apoptosis by Down-Regulating the CNPY2 Signaling Pathway
por: Zhao, Lina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_thhh7s93n3n1ob6cbjf1s3cs34